By Ben LevisohnUBS analyst Mathhew Roden and team still like biotech stocks, but think it’s time to get more selective, recommending “high quality risk reward names” like Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX), while downgrading Amgen (AMGN) and Regeneron Pharmaceuticals (REGN). They explain why:
Freya Ingrid Morales/Bloomberg News
Although we still think that biotech will continue to outperform the broader markets […]
File 2008/Getty Images(Photo by Mario Tama/Getty Images)Update at 5:03 p.m.: Trading is halted in RadioShack stock and the New York Stock Exchange has started the process to delist its shares. Shares ended trading at 24 cents on the NYSE. The company’s stock will continue to trade in the over-the-counter market.Related
RadioShack is expected to announce store closings
RadioShack’s small town strategy ruled
Schnurman: […]
By Ben LevisohnRBC’s Michael Yee and team explain why Celgene (CELG), Biogen Idec (BIIB), Vertex Pharmaceuticals (VRTX), BioMarin Pharmaceutical (BMRN) and Regeneron Pharmaceuticals (REGN) are their top biotech stocks for 2015:
Bloomberg News
Top-five longs: Celgene, Biogen Idec, BioMarin Pharmaceutical, Vertex Pharmaceuticals, Regeneron Pharmaceuticals: 1) Celgene we predict “settlement” with Actavis (ACT) could happen after spring when expert discovery ends and before Court begins mid-15; plus investors should start giving […]
By
Jacob Gershman
[email protected]
Biography
CONNECT
[email protected]
Biography
The court’s move to overturn convictions of Anthony Chiasson, left, and Todd Newman, right, comes as Michael Steinberg, center, plans to appeal his conviction on similar grounds.
From left: Bloomberg News; Associated Press; Bloomberg News
Manhattan U.S. Attorney Preet Bharara had enjoyed a nearly untarnished winning streak of insider-trading prosecutions since he took office in 2009, earning a reputation as Wall […]
While New Zealand’s stock market is the 3rd smallest among AsiaPac exchanges, it is not immune from the “glitches” even the largest exchanges have become used to in the new normal era of ‘liquidity providers’. For the 2nd time this month, equities trading in New Zealand (the entire market) is halted after a “technical fault” at the operator of the […]
There has been a consistent flow of articles in the mainstream press, such as the Wall Street Journal, Bloomberg News, and the New York Times, expounding on the growing cash pile among established mutual funds that are focused on value stocks.
Most of the funds concentrate on large-cap stocks, but not exclusively. The managers have usually been at the […]
